Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Current Oncology (Toronto, Ont.)
|
April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Shubham Sharma, J Connor Wells, Wilma M Hopman, et al.
Journal of Oncology Practice
|
July 16, 2019
Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
Timothy P Hanna, Paul Nguyen, Joseph Pater, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2023
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
Julie Stakiw, Shruthi Kodad, Richard LeBlanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2015
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome
Jose G Monzon, Annette E Hay, Gail T McDonald, et al.
Clinical Trials (London, England)
|
November 24, 2018
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes
Annette E Hay, Joseph L Pater, Elyse Corn, et al.
The Oncologist
|
May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
Arjun Gupta, Annette E Hay, Michael Crump, et al.
Journal of the National Cancer Institute
|
March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience
Joseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
Hira Mian, Jolie Ringash, Ralph Meyer, et al.
The Oncologist
|
June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 Trial
Arjun Gupta, Tyler Thomas, Annette E Hay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature
Bethany E Monteith, Christopher P Venner, Donna E Reece, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Current Oncology (Toronto, Ont.)
|
April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Shubham Sharma, J Connor Wells, Wilma M Hopman, et al.
Journal of Oncology Practice
|
July 16, 2019
Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?
Timothy P Hanna, Paul Nguyen, Joseph Pater, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 1, 2023
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
Julie Stakiw, Shruthi Kodad, Richard LeBlanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2015
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome
Jose G Monzon, Annette E Hay, Gail T McDonald, et al.
Clinical Trials (London, England)
|
November 24, 2018
Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes
Annette E Hay, Joseph L Pater, Elyse Corn, et al.
The Oncologist
|
May 25, 2023
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
Arjun Gupta, Annette E Hay, Michael Crump, et al.
Journal of the National Cancer Institute
|
March 24, 2021
Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience
Joseph C Del Paggio, Adam M Fundytus, Wilma M Hopman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
Hira Mian, Jolie Ringash, Ralph Meyer, et al.
The Oncologist
|
June 12, 2025
The Association of Health Care Contact Days with Economic Measures in the CCTG LY.12 Trial
Arjun Gupta, Tyler Thomas, Annette E Hay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 19, 2020
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature
Bethany E Monteith, Christopher P Venner, Donna E Reece, et al.
Page
of 6